Admission Date:  [**2131-6-29**]              Discharge Date:   [**2131-7-18**]  Date of Birth:  [**2087-4-16**]             Sex:   F  Service: MEDICINE  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 348**] Chief Complaint: Jitteriness  Major Surgical or Invasive Procedure: Thoracenteses (2 right lung) Peripherally inserted central catheter (right) Video assisted thoracoscopy (right)   History of Present Illness: 44 yo F with h/o EtOH abuse and h/o at least one alcohol w/drawl sz, presents with jitteriness.
also recd banana bag and additional thiamne and folate.
CXR showed RLL opacity and she was given levoflox and cefepime for PNA.
She is on disability for her depression, and supports herself with SSI and regular Masshealth managed care.
Physical Exam: On admission: 100.1 120 130/80 30 96/6l NC sleepy.
answers questions for a couple of seconds and then drifts back to sleep Chest: crackles L side.
nl s1 s2 Extr: no edema Abd: soft, NT, ND, no HSM, surgical scar +  On discharge: Tm: 101.8  Tc: 98.9  BP: 120/80  HR: 95  RR:  18 Pt is rousable, pleasant CVS: regular, no murmur Lungs: Pleural rub with mildly decreased breath sounds on the right Abd: soft, NT, obese, NABS Ext: no edema, WWP   Pertinent Results: PERTINENT LABS: [**2131-6-29**] WBC-4.4 RBC-4.25 HGB-13.7 HCT-39.6 MCV-93 PLT COUNT-399 [**2131-6-29**] NEUTS-64.1 LYMPHS-22.0 MONOS-11.5* EOS-1.6 BASOS-0.8 [**2131-6-29**] GLUCOSE-130* UREA N-6 CREAT-0.8 SODIUM-132* POTASSIUM-8.1* CHLORIDE-99 TOTAL CO2-21 [**2131-6-29**] 03:30AM   ASA-NEG ETHANOL-56* ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-POS [**2131-6-29**] ALT-47* AST-41* LD(LDH)-303* AlkPhos-111 TotBili-0.2 [**2131-6-29**] Amylase-37  Lipase-21 [**2131-6-29**] 06:25AM CK(CPK)-257* CK-MB-3 cTropnT-<0.01 proBNP-347* [**2131-6-29**] TSH-1.1 [**2131-6-29**] T4-4.8 [**2131-6-29**] Lactate-2.5  MICRO DATA: [**6-29**] BLOOD CX: no growth [**6-29**] URINE CX: no growth [**6-29**] URINARY LEGIONELLA Ag: negative [**7-1**] BLOOD CX: no growth [**7-1**] URINE CX: no growth [**7-2**] BLOOD CX: no growth [**7-4**] BLOOD CX: no growth to date [**7-4**] URINE CX: yeast 10,000-100,000 org/ml [**7-6**] BLOOD/FUNGAL/AFB CX: no growth to date [**7-7**] BLOOD CX: no growth to date  [**6-29**] PLEURAL FLUID: GRAM STAIN (Final [**2131-6-29**]):       4+   (>10 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
There is a moderate-sized right pleural effusion obscuring the right hemidiaphragm and right heart border with adjacent consolidation.
Phrenic lymph node measures 5 mm.
#Hypoxic respiratory distress:  She initially presented with hypoxic respiratory failure and a 6L oxygen requirement.
Pt was initially started on levofloxacin and Unasyn to empirically cover for aspiration and community-acquired pneumonia.
ID, Pulmonary, and Thoracic Surgery were consulted.
A VATS procedure was scheduled both for diagnostic and therapeutic uses.
DPH was contact[**Name (NI) **] about her brother's original case.
The file indicated pan-sensitivities so an oral drug regimen recommended by ID was started on [**2131-7-15**].
Three concentrated respiratory sputum samples were negative for acid fast bacilli as of [**2131-7-17**], however, given her exposure and clinical picture, the patient was started on empiric weight bases therapy prior to her discharge from [**Hospital3 **].
# Pleural TB: The patient has presumed pleural tuberculosis, for which she is currently being treated with multi-drug therapy.
The duration of this therapy will be at the discretion of the infectious disease physicians at the [**Hospital1 **].
She will have observed therapy until decided otherwise.
She was maintained on Tylenol around the clock with opioids as adjunct therapy.
Titration of her pain medications has been complicated by somnolence.
Initially she was treated with levofloxacin and Unasyn to cover for aspiration and community-acquired pneumonia.
All culture data including pleural fluid, blood, and urine was negative.
By transfer to the medical floor, she was still exhibiting signs of withdrawal including anxiety, tremulousness, and tachycardia but improving.
She was supplemented with thiamine and folate.
Notably the patient was on a home dose of Doxepin at the time of presentation.
It was discontinued during this admission and the patient was instead started on citalopram and olanzapine.
She had flashed on [**6-29**] and was started on nitro gtt for 24 hrs as above.
BB was started given the cardiomyopathy once the patient was out of the window of acute withdrawal.
Post-VATS operation, she likely became hypotensive (to 80's) and most likely from the inflammatory response to surgery, aggressive post-operative pain control, and sub-optimal systolic output.
Upon re-admission the the medical floor, the patient has had no crackles or examples or other indications of volume overload even with fluid replacement (up to 1 L/day at 100ml/hr) to aid with ARF.
Metoprolol was started given her cardiomyopathy.
The patient began having regular rate and rhythm several days after beginning TB drug therapy and receiving minor fluid resuscitation.
Her renal function improved with fluids and time.
# General Anxiety Disorder:  She was initially on a CIWA scale receiving large quantities of Valium.
When this was discontinued she was transitioned to Ativan 0.5 mg TID prn, which controlled her anxiety well.
Ipratropium Bromide 0.02 % Solution Sig: One (1) neb Inhalation Q4H (every 4 hours) as needed.
Senna 8.6 mg Tablet Sig: 1-2 Tablets PO BID (2 times a day) as needed for constipation.
Citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Nicotine 14 mg/24 hr Patch 24 hr Sig: One (1) Patch 24 hr Transdermal DAILY (Daily).
Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 hours) as needed.
Olanzapine 10 mg Tablet Sig: One (1) Tablet PO HS (at bedtime).
Acetaminophen 500 mg Tablet Sig: Two (2) Tablet PO Q8 ().
Metoprolol Tartrate 25 mg Tablet Sig: 0.5 Tablet PO BID (2 times a day).
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Pyridoxine 50 mg Tablet Sig: One (1) Tablet PO DAILY 14.
Rifampin 300 mg Capsule Sig: Two (2) Capsule PO Q24H (every 15.
Isoniazid 300 mg Tablet Sig: One (1) Tablet PO DAILY 16.
Morphine 30 mg Tablet Sustained Release Sig: One (1) Tablet Sustained Release PO Q12H (every 12 hours).
Morphine 15 mg Tablet Sig: 0.5-1 Tablet PO Q4H (every 4 hours) as needed.
Ethambutol 400 mg Tablet Sig: Three (3) Tablet PO DAILY 19.
Pyrazinamide 500 mg Tablet Sig: Three (3) Tablet PO DAILY   Discharge Disposition: Extended Care  Facility: [**Hospital6 2222**] - [**Location (un) 538**]  Discharge Diagnosis: Primary: # Alcohol withdrawal # Pneumonia with parapneumonic effusion # Urinary tract infection # Acute renal failure  Secondary: # Anemia # Depression/anxiety # Cardiomyopathy   Discharge Condition: Patient is 8 days s/p thorascopy.
Pain is adequately controlled on her current medication regimen.
You were treated for alcohol withdrawal with medication and the pneumonia with antibiotics.
You had two thoracentesis where fluid was removed from your lungs.
You were found to have a urinary tract infection which was treated in conjunction with your pneumonia.
Two chest tubes were placed for drainage which were later removed and you were started on medication to manage pain.
Followup Instructions: You are being transferred to [**Hospital **] Hospital for completion of your medical care specifically to help you take your tuberculosis medication and manage your pain.
